-
Analysed clinical and market potential for entry into the NSCLC market
-
Evaluated unmet needs to identify potential entry points
-
Conducted a deep-dive study of key assets and key players
CLIENT CHALLENGES
- A Japanese pharmaceutical company wanted to assess the viability of entering the NSCLC market
- Key challenges were :
- Understanding and assessing the NSCLC market, which has numerous assets
- Undertaking a competitive assessment of pipeline drugs to identify potential drugs
- Understanding regulatory approvals, reimbursement and market access in the NSCLC market
- Evaluating unmet needs, barriers, drivers for charting the wayout
OUR APPROACH
- Competitive landscape :
- Understanding the current SoC, and epidemiology of NSCLC
- Understanding diagnostic tests available and associated treatments available
- Mapping different assets in the NSCLC pipeline against LOT and target
- Benchmarking assets :
- Evaluating the safety and efficacy of approved drugs to understand benchmarking in different patient segments
- Competitive assessment of pipeline drugs to identify potential drugs
- Viability assessment :
- Evaluating unmet needs, barriers, drivers for charting the wayout
- Understanding the launch timeline, assessment of pricing, reimbursement and CDx considerations
IMPACT DELIVERED
- Helped the client’s team understand the landscape of the NSCLC market, considering both approved and ongoing trials
- Advised on viability of entering the NSCLC market using different parameters
Thank you for sharing your details
Your file will start downloading automatically
If it does not download within 1 minute,
Share this on
